Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction

Aim. To assess non-invasive parameters of left ventricular (LV) myocardial work in patients with heart failure with reduced ejection fraction (CHrEF) and iron deficiency (ID) after ferric carboxymaltose (FCM) therapy.Material and methods. There were following inclusion criteria: LV ejection fraction...

Full description

Saved in:
Bibliographic Details
Main Authors: Zh. D. Kobalava, A. F. Safarova, A. A. Lapshin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5310
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689697238908928
author Zh. D. Kobalava
A. F. Safarova
A. A. Lapshin
author_facet Zh. D. Kobalava
A. F. Safarova
A. A. Lapshin
author_sort Zh. D. Kobalava
collection DOAJ
description Aim. To assess non-invasive parameters of left ventricular (LV) myocardial work in patients with heart failure with reduced ejection fraction (CHrEF) and iron deficiency (ID) after ferric carboxymaltose (FCM) therapy.Material and methods. There were following inclusion criteria: LV ejection fraction (EF) ≤40%; body >70 kg, receiving best medical therapy (BMT) in recommended doses in accordance with the guidelines of the European Society of Cardiology and the Russian Society of Cardiology. Median age was 67±11,7 years (men, 83%), while median LVEF and N-terminal pro-brain natriuretic peptide was 29% and 315 ng/ml, respectively. Patients were randomized by the envelope method. The first group consisted of 19 patients who received therapy with intravenous FCM 1500 mg in 2 injections with an interval of one week between injections in addition to BMT. The control group consisted of 16 patients who received BMT without FCM. All patients underwent a standard echocardiography, and non-invasive LV myocardial work was assessed immediately before inclusion in the study and after 3 months.Results. In the first group of patients receiving FCM therapy, an increase in LVEF (29,1±10,3 vs 35,4±11,1; p=0,001), mitral annular plane systolic excursion (1,2 (1;1,6 ) vs 1,5 (1,3;1,9), p=0,001), LV global longitudinal strain (-7 (-5;-8) vs -8 (-6;-11), p=0,007) and non-invasive indicators of myocardial work (global work index (826±314 vs 1041±354), p=0,0001; global constructive work (1173±388 vs 1435±405), p=0,0001; global work efficiency (85 (82;87) vs 86 (82;88), p=0,017)). There were no significant changes in the studied parameters in the BMT group.Conclusion. Patients with HFrEF and ID treated with FCM showed a significant increase in LV systolic function, including non-invasive myocardial work parameters, compared with the control group.
format Article
id doaj-art-e0de3eba44444b36af3fd9050645675d
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2023-02-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-e0de3eba44444b36af3fd9050645675d2025-08-20T03:21:32Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-02-0128110.15829/1560-4071-2023-53103743Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fractionZh. D. Kobalava0A. F. Safarova1A. A. Lapshin2Peoples’ Friendship University of RussiaPeoples’ Friendship University of RussiaPeoples’ Friendship University of RussiaAim. To assess non-invasive parameters of left ventricular (LV) myocardial work in patients with heart failure with reduced ejection fraction (CHrEF) and iron deficiency (ID) after ferric carboxymaltose (FCM) therapy.Material and methods. There were following inclusion criteria: LV ejection fraction (EF) ≤40%; body >70 kg, receiving best medical therapy (BMT) in recommended doses in accordance with the guidelines of the European Society of Cardiology and the Russian Society of Cardiology. Median age was 67±11,7 years (men, 83%), while median LVEF and N-terminal pro-brain natriuretic peptide was 29% and 315 ng/ml, respectively. Patients were randomized by the envelope method. The first group consisted of 19 patients who received therapy with intravenous FCM 1500 mg in 2 injections with an interval of one week between injections in addition to BMT. The control group consisted of 16 patients who received BMT without FCM. All patients underwent a standard echocardiography, and non-invasive LV myocardial work was assessed immediately before inclusion in the study and after 3 months.Results. In the first group of patients receiving FCM therapy, an increase in LVEF (29,1±10,3 vs 35,4±11,1; p=0,001), mitral annular plane systolic excursion (1,2 (1;1,6 ) vs 1,5 (1,3;1,9), p=0,001), LV global longitudinal strain (-7 (-5;-8) vs -8 (-6;-11), p=0,007) and non-invasive indicators of myocardial work (global work index (826±314 vs 1041±354), p=0,0001; global constructive work (1173±388 vs 1435±405), p=0,0001; global work efficiency (85 (82;87) vs 86 (82;88), p=0,017)). There were no significant changes in the studied parameters in the BMT group.Conclusion. Patients with HFrEF and ID treated with FCM showed a significant increase in LV systolic function, including non-invasive myocardial work parameters, compared with the control group.https://russjcardiol.elpub.ru/jour/article/view/5310heart failure with reduced ejection fractioniron deficiencymyocardial work
spellingShingle Zh. D. Kobalava
A. F. Safarova
A. A. Lapshin
Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
Российский кардиологический журнал
heart failure with reduced ejection fraction
iron deficiency
myocardial work
title Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
title_full Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
title_fullStr Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
title_full_unstemmed Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
title_short Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
title_sort influence of intravenous ferric carboxymaltose on non invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
topic heart failure with reduced ejection fraction
iron deficiency
myocardial work
url https://russjcardiol.elpub.ru/jour/article/view/5310
work_keys_str_mv AT zhdkobalava influenceofintravenousferriccarboxymaltoseonnoninvasiveparametersofleftventricularmyocardialworkinpatientswithheartfailurewithreducedejectionfraction
AT afsafarova influenceofintravenousferriccarboxymaltoseonnoninvasiveparametersofleftventricularmyocardialworkinpatientswithheartfailurewithreducedejectionfraction
AT aalapshin influenceofintravenousferriccarboxymaltoseonnoninvasiveparametersofleftventricularmyocardialworkinpatientswithheartfailurewithreducedejectionfraction